A detailed history of Argent Trust CO transactions in Natera, Inc. stock. As of the latest transaction made, Argent Trust CO holds 2,679 shares of NTRA stock, worth $435,042. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,679
Previous 3,061 12.48%
Holding current value
$435,042
Previous $331,000 2.72%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$97.75 - $129.67 $37,340 - $49,533
-382 Reduced 12.48%
2,679 $340,000
Q1 2024

May 10, 2024

BUY
$59.21 - $92.9 $181,241 - $284,366
3,061 New
3,061 $279,000
Q4 2021

Feb 09, 2022

SELL
$86.26 - $119.0 $160,098 - $220,864
-1,856 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$100.17 - $126.36 $7,913 - $9,982
79 Added 4.45%
1,856 $207,000
Q2 2021

Aug 09, 2021

BUY
$86.05 - $119.72 $152,910 - $212,742
1,777 New
1,777 $202,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Argent Trust CO Portfolio

Follow Argent Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Argent Trust CO with notifications on news.